retatrutide clinical trial results weight loss efficacy Results: 28.3% Data Retatrutide: A Triple Agonist Shaping

Figure 4 summarises the 3-year adverse events

New clinical data and review of the literature

While this is a key research area, we propose that further investigations should verify whether GLP-1RAs may also affect cognitive and behavioral symptoms seen in psychosis, as suggested by their potential to influence neurobiological (for example, immune function) and neuropsychological (for example, reward) mechanisms that are known to be disrupted in psychotic illness

The problem was not the plant itself but the bias baked into the system

You dont need a special diet, but youll see better results with protein-forward and lower-fat meals, plenty of water, and regular activity like walking and light resistance work

Be very cautious if youre on metformin